nach oben

Current Breast Cancer Reports

Erschienen in:

26.05.2020 | Breast Cancer Disparities (LA Newman, Section Editor)

Large Datasets for Disparities Research in Breast Cancer

verfasst von: Alex Cheng, Jerome Jourquin, Mia Levy

Erschienen in: Current Breast Cancer Reports | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Breast cancer disparities affect how different populations are impacted by breast cancer incidence, mortality, and survival. We provide an overview of large datasets that scientists can use to study disparities in breast cancer outcomes.

Recent Findings

Many large datasets are accessible to disparities researchers with a project plan and little or no cost. Yet only two datasets have been significantly used in breast cancer disparities publications. Other datasets combine administrative claim, molecular, electronic health record, patient reported, imaging, and clinical trial data in a way that could benefit disparities research.

Summary

Many existing datasets lack sufficient diversity or detail in key disparity variables. With this review of the different datasets available and their potential pitfalls, researchers will be better equipped to conduct studies that can identify and solve the problems that lead to health outcome disparities for breast cancer patients.

Bigby JA, Holmes MD. Disparities across the breast cancer continuum. Cancer Causes Control. 2005:35–44.

Braveman PA, Kumanyika S, Fielding J, LaVeist T, Borrell LN, Manderscheid R, et al. Health disparities and health equity: the issue is justice. Am J Public Health. 2011;101:S149–55.CrossRef

Wang JJ, Health N, Oluwole SF, Hiotis K, Bickell NA, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. Artic J Clin Oncol. 2006;24:1357–62 [cited 2020 Jan 27] https://www.researchgate.net/publication/7228818. Accessed 30 Jan 2020.

Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomark Prev. 2009;18:121–31.CrossRef

Burgess DJ, Fu SS, Van Ryn M. Why do providers contribute to disparities and what can be done about it? J Gen Intern Med. 2004:1154–9.

• Chambers DA, Amir E, Saleh RR, Rodin D, Keating NL, Osterman TJ, et al. The impact of big data research on practice, policy, and cancer care. Am Soc Clin Oncol Educ B. American Society of Clinical Oncology (ASCO). 2019:e167–75 This book chapter highlights the types of big data available for observational cancer research studies. The authors include details about the strengths and weakness of each source of data as well as examples for studies that have used big data to improve cancer care.

•• Reeder-Hayes KE, Troester MA, Meyer A-M. Reducing racial disparities in breast cancer care: the role of “big data.”. Oncology. 2017;31:756–62 This paper addresses the opportunities and challenges of working with big data in reducing disparities in breast cancer, particularly with regard to racial disparities. The authors highlight several large datasets used for disparities research such as SEER-Medicare and the Carolina Breast Cancer Study. They also identify some datasets with with potential for big data research such as Flatiron and CancerLinQ. PubMed

Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. Cancer. 2007 [cited 2020 Jan 27], 109:359. https://doi.org/10.1002/cncr.22354.

Daly B, Olopade OI. A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015 [cited 2020 Jan 27];65:221–38. https://doi.org/10.3322/caac.21271.CrossRefPubMed

10.

Abbott DE, Voils CL, Fisher DA, Greenberg CC, Safdar N. Socioeconomic disparities, financial toxicity, and opportunities for enhanced system efficiencies for patients with cancer. J Surg Oncol. 2017 [cited 2020 Jan 27];115:250–6. https://doi.org/10.1002/jso.24528.CrossRefPubMed

11.

• Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584–91 Nature Publishing Group. his paper illustrates the problem with developing polygenic risk scores on racially homogenous populations. Risk scores are more accurate for individuals of European ancestry since data to develop the risk models are trained on primarily individuals of European ancestry. These findings underscore the importance of diversifying large datasets and increasing transparency of variables related to disparities in clinical research. CrossRef

12.

Buolamwini J, Gebru T. Gender shades: intersectional accuracy disparities in commercial gender classification. Proc Mach Learn Res. 2018.

13.

•• Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(80):447–53 This paper uncovers racial bias in a widely used risk prediction algorithm. In this study, researchers discovered that black patients were assigned lower risk scored compared to white patients with the same comorbidities. This occurred because the model was trained using cost of care as the outcome, and hospitals in the past had spent more on white patients than black patients. This real-world example of the failure of a prediction model trained on big data is a cautionary tale that even diverse datasets can perpetuate existing disparities. CrossRef

14.

Reeder-Hayes KE, Bainbridge J, Meyer AM, Amos KD, Weiner BJ, Godley PA, et al. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat. 2011;128:863–71.CrossRef

15.

Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. [cited 2020 Jan 27]. 27:713–9 www.jco.org. Accessed 30 January 2020.

16.

Walker GV, Grant SR, Guadagnolo BA, Hoffman KE, Smith BD, Koshy M, et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol. 2014;32:3118–25.

17.

Niu X, Roche LM, Pawlish KS, Henry KA. Cancer survival disparities by health insurance status. Cancer Med. 2013 [cited 2020 Jan 27];2:403–11. https://doi.org/10.1002/cam4.84.CrossRefPubMedPubMedCentral

18.

Krieger N. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002 [cited 2020 Jan 27];;156:471–82. https://doi.org/10.1093/aje/kwf068.CrossRefPubMed

19.

Bronson MR, Kapadia NS, Austin AM, Wang Q, Feskanich D, Bynum JPW, et al. Leveraging linkage of cohort studies with administrative claims data to identify individuals with cancer. Med Care. 2018;56:e83–9.

20.

NCI Brief description of SEER-Medicare Database [Internet]. [cited 2019 Feb 21]. https://healthcaredelivery.cancer.gov/seermedicare/overview/. Accessed 30 Jan 2020.

21.

National Cancer Database [Internet]. [cited 2020 Jan 31]. Available from: https://www.facs.org/quality-programs/cancer/ncdb. Accessed 30 Jan 2020.

22.

Newman LA. Breast cancer disparities: socioeconomic factors versus biology. Ann Surg OncolSpringer New York LLC. 2017;24:2869–75.CrossRef

23.

Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist Alphamed Press. 2013;18:986–93.CrossRef

24.

Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Women’s Heal. 2009;18:883–93.CrossRef

25.

Patel TA, Colon-Otero G, Bueno Hume C, Copland JA, Perez EA. Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups. Oncologist. Alphamed Press. 2010;15:466–75.CrossRef

26.

Hamdan D, Nguyen TT, Leboeuf C, Meles S, Janin A, Bousquet G. Genomics applied to the treatment of breast cancer. Oncotarget. Impact Journals LLC. 2019:4786–801.

27.

OHDSI. Data standardization [Internet]. [cited 2020 Jan 31]. https://www.ohdsi.org/data-standardization/. Accessed 30 January 2020.

28.

Wang MC, Mosen D, Shuster E, Bellows J. Association of patient-reported care coordination with patient satisfaction. J Ambul Care Manage. 2015;38:69–76 [cited 2018 Apr 30] http://insights.ovid.com/crossref?an=00004479-201501000-00011.CrossRef

29.

McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. International evaluation of an AI system for breast cancer screening. Nature Nature Research. 2020;577:89–94.CrossRef

30.

Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R. A deep learning mammography-based model for improved breast cancer risk prediction. Radiology. 2019 [cited 2020 Jan 27];292:60–6. https://doi.org/10.1148/radiol.2019182716.CrossRefPubMed

31.

Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol Springer New York. 2007;14:3328–34.CrossRef

32.

Number of respondents by (selected) first cancer site and date of diagnosis: Medicare advantage [Internet]. [cited 2019 Nov 15]. Available from: https://healthcaredelivery.cancer.gov/seer-cahps/aboutdata/diagnosis-ma.html

33.

Demographic characteristics of SEER-CAHPS respondents by health plan type [Internet]. [cited 2019 Nov 15]. Available from: https://healthcaredelivery.cancer.gov/seer-cahps/aboutdata/demographics.html. Accessed 30 Jan 2020.

34.

Number of cancer cases for selected cancers in the SEER-Medicare data [Internet]. [cited 2019 Nov 15]. Available from: https://healthcaredelivery.cancer.gov/seermedicare/aboutdata/cases.html. Accessed 30 Jan 2020.

35.

SEER-MHOS data: number of SEER-MHOS respondents (age 65+) by first cancer site, 1998–2017 [Internet]. [cited 2019 Nov 15]. Available from: https://healthcaredelivery.cancer.gov/seer-mhos/aboutdata/table.cancer.site.html. Accessed 30 Jan 2020.

36.

SEER-MHOS data: demographic characteristics for MHOS (1998-2017) respondents (age 65+) with completed survey before or after their first cancer diagnosis, and those without cancer [Internet]. [cited 2019 Nov 15]. Available from: https://healthcaredelivery.cancer.gov/seer-mhos/aboutdata/table.demographics.html. Accessed 30 Jan 2020.

37.

Humes KR, Jones NA, Ramirez RR. Overview of race and Hispanic origin: 2010 census briefs [Internet] 2010. Available from: www.whitehouse.gov/omb. Accessed 30 Jan 2020.

38.

Susan G. Komen®. Age [Internet]. [cited 2020 Jan 31]. Available from: https://ww5.komen.org/BreastCancer/GettingOlder.html

39.

American Cancer Society. Breast cancer facts & figures. 2017.

40.

US Census Bureau. Income, poverty, and health insurance: 2018. 2019.

41.

Thorpe KE, Howard D. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003;Suppl Web Exclusives.

42.

Bureau UC. American Community Survey (ACS).

43.

USDA ERS - Rural-urban continuum codes [Internet]. [cited 2020 Jan 27]. Available from: https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx. Accessed 30 Jan 2020.

44.

Mapping Broadband Health in America | Federal Communications Commission [Internet]. [cited 2020 Jan 27]. Available from: https://www.fcc.gov/health/maps. Accessed 30 Jan 2020.

45.

Search SEER Linkage Publications [Internet]. [cited 2019 Nov 15]. Available from: https://healthcaredelivery.cancer.gov/publications/. Accessed 30 Jan 2020.

Titel: Large Datasets for Disparities Research in Breast Cancer
verfasst von: Alex Cheng
Jerome Jourquin
Mia Levy
Publikationsdatum: 26.05.2020
Verlag: Springer US
Erschienen in: Current Breast Cancer Reports / Ausgabe 3/2020
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI: https://doi.org/10.1007/s12609-020-00367-y

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Large Datasets for Disparities Research in Breast Cancer

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Breast Reconstruction Disparities in the United States and Internationally

Surgical Approaches to the Prevention and Management of Breast Cancer–Related Lymphedema

Disparities in Genetic Testing and Care Among Black Women with Hereditary Breast Cancer

Integrating Biology and Access to Care in Addressing Breast Cancer Disparities: 25 Years’ Research Experience in the Carolina Breast Cancer Study

Breast Cancer Health Disparities in Hispanics/Latinas

Do Women with Breast Cancer–related Lymphoedema Need to Wear Compression While Exercising?: Results from a Systematic Review and Meta-analysis

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie